Modernization and the Rising Burden of IBD: New Insights From a Global Study | Docwire News
The developed scale strengthens the investigation of global irritable bowel disease epidemiology.
Related Articles
Bloomberg – Business News, Stock Markets, Finance, Breaking & World News
Bloomberg delivers business and markets news, data, analysis, and video to the world, featuring stories from Businessweek and Bloomberg News
Earth and Environmental News, Videos and Images
At Earth.com, our goal is to provide the internet with a homepage for anything and everything about our planet Earth and the environment.
Epigenetic Age Acceleration Mediates Treatment Effects on Cardiometabolic and Cardiovascular Risk in Childhood Cancer Survivors:
AbstractBackgroundChildhood cancer survivors are at increased risk for epigenetic age acceleration (EAA) and subsequent morbidities—including cardiometabolic risk factors (CMRFs) and cardiovascular…
IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert Panel
AbstractAnthracycline and anthraquinone agents are major contributors to cancer therapy–related cardiac dysfunction in childhood cancer. However, evidence-based equivalence ratios for estimating in…
Extra Virgin Olive Oil is Better than Ozempic Greek City Times
Greek City Times Extra Virgin Olive Oil is Better than Ozempic
Which cooking oil is the healthiest — olive, avocado or coconut?
Seeds oils are being demonised on social media, and even olive oil is not without its critics. Peta Bee asks the health experts what they…
Day, Night, and the Liver
Liver by Day & Night Most people have just a vague idea of what the liver does. They know it’s used to remove toxins from…
DYNAMIC-III: ctDNA-Guided Chemo for Stage III Colon Cancer | GI Oncology Now
Professor Tie discusses DYNAMIC-III, a trial using ctDNA to guide chemo escalation in stage III colon cancer.
AI to Determine ARPI Benefit for Non-Metastatic Prostate Cancer | GU Oncology Now
Dr. James showcases an MMAI model to identify benefit from 2nd-generation ARPIs in hr/nm PCa patients from STAMPEDE.
Novel Calreticulin-Mutation-Targeting Antibody Safe, Effective for High-Risk ET | Blood Cancers Today
Dose escalation study data presented at EHA2025 showed durable response in patients with disease resistant to prior therapy.
